TARGETED INHIBITION OF LEUKEMIA INHIBITORY FACTOR (LIF)/ LIFR AXIS FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Vadlamudi, Ratna K

Funded by

ARMY MED RESEARCH ACQUISITION ACTIVITY

Research Start Date

05/01/2018

Status

Active

Collaborative Project

Clinical Care

Cancer

Bioscience Research Panel